As of 2024-12-13, the Intrinsic Value of Oncozenge AB (ONCOZ.ST) is
-5.03 SEK. This ONCOZ.ST valuation is based on the model Peter Lynch Fair Value.
With the current market price of 3.90 SEK, the upside of Oncozenge AB is
-228.96%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-5.03 SEK
Intrinsic Value
ONCOZ.ST Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-5.03 - -5.03 |
-5.03 |
-228.96% |
| DDM - Stable |
(5.07) - (10.40) |
(7.73) |
-298.3% |
| DDM - Multi |
(5.67) - (9.18) |
(7.02) |
-280.1% |
ONCOZ.ST Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
45.68 |
| Beta |
1.51 |
| Outstanding shares (mil) |
11.71 |
| Enterprise Value (mil) |
38.11 |
| Market risk premium |
5.10% |
| Cost of Equity |
15.30% |
| Cost of Debt |
5.00% |
| WACC |
9.80% |